Login to Your Account



Pharma: Other News To Note


Friday, March 16, 2012
• Watson Pharmaceuticals Inc., Parsippany, N.J., said its subsidiary filed an abbreviated new drug application for Nebivolol hydrochloride tablets, a generic version of New York-based Forest Laboratories Inc.'s Bystolic, a beta-adrenergic blocking agent for use in hypertension.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription